Deutsche Bank’s Mateon Therapeutics MATN Stock Holding History
Bought
Maintained
Sold
Other funds holding MATN
Deutsche Bank's MATN Position: Q4 2016 in Review
Deutsche Bank sold out of Mateon Therapeutics (MATN) in Q4 2016, closing a stake of 9 shares.
Deutsche Bank first reported a position in MATN in Q2 2016 and held it in 2 quarters. The position peaked at $0 in Q3 2016. 1 fund tracked by Wall St. Rank holds MATN as of Q4 2016.
- Deutsche Bank reported no remaining Mateon Therapeutics position as of Q4 2016 after selling out during the quarter.
- Deutsche Bank sold 9 Mateon Therapeutics shares in Q4 2016.
- Deutsche Bank first reported a position in Mateon Therapeutics in Q2 2016 and held it in 2 quarters.
- Deutsche Bank's Mateon Therapeutics position peaked at $0 in Q3 2016.
- 1 fund tracked by Wall St. Rank held Mateon Therapeutics as of Q4 2016.
Based on Deutsche Bank's 13F filing for Q4 2016, filed 14 Feb 2017.